Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EAGLE-HF is Part of a Multinational Group of Studies Titled; Screening for Early Heart Failure Diagnosis and Management in Primary Care or at Home Using Natriuretic Peptides and Echocardiography

NCT06849752 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT06849752
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06849752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EAGLE-HF is Part of a Multinational Group of Studies Titled; Screening for Early Heart Failure Diagnosis and Management in Primary Care or at Home Using Natriuretic Peptides and Echocardiography
Lead sponsor
The Cleveland Clinic
Phase
Observational
Overall status
Recruiting
Start date
March 11, 2025
Completion date
December 31, 2031
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, socioeconomic adversity